Drug-induced fixed urticaria because of hypersensitivity to non steroidal anti-inflammatory drugs
Main Article Content
Keywords
NSAID hypersensitivity, fixed drug eruption, familial aggregation, pediatrics, drug-induced fixed urticarial
Abstract
Drug-induced fixed urticaria (DIFU) is a rare skin reaction, characteri zed by pruritic hives that reappear in the same location after exposure to the triggering drug. In the few cases reported in the literature, it is considered as an atypical variant of fixed drug eruption (FDE). We present the case of a 10-year-old girl with allergic rhinoconjunctivitis, who had experienced three episodes of localized urticaria on the dorsal surface of both arms, 1 hour after taking ibuprofen. These manifestations did not appear when taking paracetamol, which she tolerated. Her father suffers from generalized urticaria to NSAIDs. An oral provocation test (OPT) was performed with ibuprofen, acetylsalicylic acid, and metamizole, which also caused the same fixed-location wheals and subsequent spontaneous resolution. She, however, tolerated an OPT with meloxicam. This case is notable because of the rarity of the DIFU and the familial aggregation of hypersensitivity to NSAIDs. In this case, as in those of DIFU described in the literature, the hives appeared shortly after the drug was administered and resolved rapidly. This feature distinguishes it from FDE, and it resembles acute drug urticaria, as in the patient’s father, which raises questions concerning the pathophysiology of DIFU.
References
2 Argiz L, Múgica MV, Vega F, Blanco C. Drug-i nduced fixed urticaria as a presentation of NSAID i ntolerance. J. Allergy Clin. Immunol. Pract. 2019 Apr 7(4):1306–7. 10.1016/j.jaip.2018.10.030
3 Gambichler T, Weyer-Fahlbusch SS, Dengler S, Schaller J, Susok L. Consistently reproducible fixed drug-induced urticaria in a patient with metastatic melanoma under immunotherapy. Acta. Derm. Venereol. 2025 May 20;105:adv43652. 10.2340/actadv.v105.43652
4 Gultekin TTK, Emeksiz ZS, Selmanoğlu A, Misirlioglu ED. Nonsteroidal anti-inflammatory drug-induced fixed urticaria: first pediatric case report. Ann Allergy Asthma Immunol. 2024 Jul 4;133(4):470–2. 10.1016/j.anai.2024.06.030
5 Çelik HI, Akay E, Emeksiz ZS, Işık M, Yaralı HN, Mısırlıoğlu ED. Pediatric hemophilia patient: successful desensitization for drug-induced fixed urticaria with prothrombin complex concentrate. Pediatr. Allergy I mmunol. 2024 Mar 1;35(3). 10.1111/pai.14105
6 Anderson HJ, Lee J.B. A Review of fixed drug eruption with a special focus on generalized bullous fixed drug eruption. Medicina 2021; 57(9):925. 10.3390/medicina57090925
7 Jurado-Escobar R, Doña I, Triano-Cornejo J, Perkins JR, Pérez-Sánchez N, Testera-Montes A, et al. Genetic variants in cytosolic phospholipase A2 associated with nonsteroidal anti-inflammatory drug-induced acute urticaria/angioedema. Front Pharmacol. 2021;12:667824. 10.3389/fphar.2021.667824
8 Mathieu A, de Grandmont M, Fernandes CL, Kechichian E. Triggers, clinical manifestations and assessment of paediatric fixed drug eruptions: a systematic review of the literature. Contact Dermatitis. 2024;90(4):343–9. 10.1111/cod.14500
9 Parker AL, Pinson ML, Wohltmann WE, Gomez R. Fixed food eruption caused by peanut and cashew: a case report and review of the literature. J. Allergy Clin. Immunol. Pract. 2015 Jan–Feb;3(1):119–22. 10.1016/j.jaip.2014.08.004
10 Vichyanond P, Tanticharoenwiwat P, Wongteerayanee C, Rutrakool N, Senavonge A, Jeekungwal N, et al. Localized abdominal urticaria: a distinct clinical phenotype of wheat allergy in young children. J. Allergy Clin. Immunol Pract. 2020 Nov-Dec 8(10):3650–3652.e1. 10.1016/j.jaip.2020.06.010